Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Endocrinology

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2008-0180PMID 18556349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Action in the Double Incretin Receptor Knockout Mouse

  2008cited by this paper
• Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.

  2007cited by this paper
• Central Insulin Regulates Heart Rate and Arterial Blood Flow

  2007cited by this paper
• The role of gut hormones in glucose homeostasis.

  2007cited by this paper
• Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia

  2007cited by this paper
• Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

  2007cited by this paper
• Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain.

  2006cited by this paper
• Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor

  2006cited by this paper
• The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem

  2005cited by this paper
• Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

  2005cited by this paper
• Long–term dietary high protein intake up–regulates tissue specific gene expression of uncoupling proteins 1 and 2 in rats

  2005cited by this paper
• Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels.

  2005cited by this paper
• New ways in which GLP-1 can regulate glucose homeostasis.

  2005cited by this paper
• Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

  2005cited by this paper
• Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.

  2004cited by this paper
• Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension.

  2004cited by this paper
• Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

  2003cited by this paper
• Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice.

  2003cited by this paper
• The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity

  2003cited by this paper
• Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains

  2002cited by this paper
• Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains.

  2002cited by this paper
• University of Groningen Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats

  2002cited by this paper
• Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet.

  2002cited by this paper
• Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.

  2001cited by this paper
• A Defect in Glycogen Synthesis Characterizes Insulin Resistance in Hypertensive Patients With Type 2 Diabetes

  2001cited by this paper
• Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

  2001cited by this paper
• Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide Synthase

  2001cited by this paper
• Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.

  2000cited by this paper
• Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization.

  2000cited by this paper
• Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1.

  2000cited by this paper
• Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice.

  2000cited by this paper
• Glucagon-like peptide-1 (7–36) amide as a novel neuropeptide

  1998cited by this paper
• Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.

  1998cited by this paper
• Novel Glucosensor for Hypoglycemic Detection Localized to the Portal Vein

  1997cited by this paper
• Intracerebroventricular injection of mammalian and chicken glucagon-like peptide-1 inhibits food intake of the neonatal chick.

  1997cited by this paper
• Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes.

  1996cited by this paper
• Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.

  1996cited by this paper
• The nerves, the liver, and the route of feeding: an integrated response to nutrient delivery.

  1996cited by this paper
• Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes.

  1996cited by this paper
• A Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm

  1996cited by this paper
• Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake

  1996cited by this paper
• Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary.

  1995cited by this paper
• Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

  1995cited by this paper
• Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain.

  1992cited by this paper
• In Vivo Insulin Resistance Induced by Amylin Primarily Through Inhibition of Insulin-Stimulated Glycogen Synthesis in Skeletal Muscle

  1991cited by this paper
• Glucagon and the Glucagon‐like Peptides

  1990cited by this paper
• Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.

  1990cited by this paper
• Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

  1990cited by this paper

• GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway

  2025cites this paper
• The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review

  2025cites this paper
• Glucagon-like peptide 1 (GLP-1) action on hypothalamic feeding circuits.

  2025cites this paper
• Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

  2024cites this paper
• Variants of the cry 1 gene may influence the effect of fat intake on resting metabolic rate in women with overweight of obesity: a cross-sectional study

  2021cites this paper
• Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics

  2021cites this paper
• MECHANISMS IN ENDOCRINOLOGY: The gut–brain axis: regulating energy balance independent of food intake

  2021cites this paper
• Long-term functional alterations following prenatal GLP-1R activation.

  2021cites this paper
• Failure of the Brain Glucagon-Like Peptide-1-Mediated Control of Intestinal Redox Homeostasis in a Rat Model of Sporadic Alzheimer’s Disease

  2021cites this paper
• High β-Glucan Barley Supplementation Improves Glucose Tolerance by Increasing GLP-1 Secretion in Diet-Induced Obesity Mice

  2021cites this paper
• The Role of Apelin/Apelin Receptor in Energy Metabolism and Water Homeostasis: A Comprehensive Narrative Review

  2021cites this paper
• Reactive Oxygen Species/Reactive Nitrogen Species as Messengers in the Gut: Impact on Physiology and Metabolic Disorders

  2021cites this paper
• GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner

  2020cites this paper
• Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss

  2019cites this paper
• Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs

  2019cites this paper
• Variants in the PPARGC1A Gene may Influence the Effect of Fat Intake on Resting Metabolic Rate in Obese Women.

  2018cites this paper
• Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

  2018cites this paper
• Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1

  2018cites this paper
• GLP-1 increases Kiss-1 mRNA expression in kisspeptin-expressing neuronal cells†

  2017cites this paper
• GLP-1R Signaling Directly Activates Arcuate Nucleus Kisspeptin Action in Brain Slices but Does not Rescue Luteinizing Hormone Inhibition in Ovariectomized Mice During Negative Energy Balance

  2017cites this paper
• Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.

  2017cites this paper
• Studies on the Character of Hypothalamic GnRH Neurons and Kisspeptin Neurons Using Hypothalamic Cell Models

  2017cites this paper
• Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.

  2016cites this paper
• Central chronic apelin infusion decreases energy expenditure and thermogenesis in mice

  2016cites this paper
• Challenges to Healthy Eating Practices

  2016cites this paper
• Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.

  2015cites this paper
• Effects of GLP-1 on appetite and body weight : focus on the central nervous system Chapter 2

  2015cites this paper
• Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity

  2015cites this paper
• PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.

  2015cites this paper
• Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice

  2015cites this paper
• Brain GLP-1 and insulin sensitivity.

  2015cites this paper
• Excess intake of fat and sugar potentiates epinephrine-induced hyperglycemia in male rats.

  2015cites this paper
• Differential Mode of Action GLP-1-Based Strategies: A Physiological Analysis of

  2015cites this paper
• Acute but not chronic activation of brain glucagon‐like peptide‐1 receptors enhances glucose‐stimulated insulin secretion in mice

  2015cites this paper
• GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

  2014cites this paper
• Uncoupling Protein-2 Mediates DPP-4 Inhibitor-Induced Restoration of Endothelial Function in Hypertension Through Reducing Oxidative Stress

  2014cites this paper
• Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice.

  2014cites this paper
• Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production.

  2014cites this paper
• Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.

  2014cites this paper
• Title Uncoupling Protein-2 Mediates DPP-4 Inhibitor-Induced Restoration of Endothelial Function in Hypertension Through Reducing Oxidative Stress

  2014cites this paper
• Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents

  2014cites this paper
• The Role of Transcription Factor 7-Like 2 in Hepatic Glucose Metabolism

  2014cites this paper
• Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS.

  2014cites this paper
• The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis

  2014cites this paper
• Role of the Glucagon and Glucagon-like Peptides in Pancreatic Beta Cell and Cardiovascular Function

  2014cites this paper
• The effect of liraglutide on microvascular complications and cardiovascular risk in patients with type 2 diabetes

  2014cites this paper
• GLP-1-based strategies: a physiological analysis of differential mode of action.

  2014cites this paper
• Instructions for Annotating Your . PDF Proof

  2014cites this paper
• Pharmacology, physiology, and mechanisms of incretin hormone action.

  2013cites this paper
• DPP4‐inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high‐fat diet consumption

  2013cites this paper
• Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates.

  2013cites this paper
• [New insights into adipose cell biology].

  2013cites this paper
• Doves, Diplomats, and Diabetes

  2013cites this paper
• High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.

  2013cites this paper
• Modulation of active glucagon-like peptide-1 (glp-1) levels by grape-seed procyanidins

  2013cites this paper
• Identificación de células enteroendocrinas productoras del peptido similar al glucagón tipo-1(glp-1) en intestinos de alpacas

  2013cites this paper
• Autonomic control and bariatric procedures.

  2013influential citation
• Glucose homeostasis can be differentially modulated by varying individual components of a western diet.

  2013cites this paper
• Diabetes in a Textbook

  2012cites this paper
• The role of the Wnt signaling pathway in incretin hormone production and function

  2012cites this paper
• Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.

  2012cites this paper
• Regulation of glucose kinetics during exercise by the glucagon‐like peptide‐1 receptor

  2012cites this paper
• The Rise and Fall of Thrift

  2012cites this paper
• Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.

  2012cites this paper
• Peripheral signalling involved in energy homeostasis control

  2012cites this paper
• Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report

  2012cites this paper
• Experience with the high-intensity sweetener saccharin impairs glucose homeostasis and GLP-1 release in rats.

  2012cites this paper
• Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales

  2012cites this paper
• Apelin Treatment Increases Complete Fatty Acid Oxidation, Mitochondrial Oxidative Capacity, and Biogenesis in Muscle of Insulin-Resistant Mice

  2012cites this paper
• Exendin-4 decreases amphetamine-induced locomotor activity.

  2012cites this paper
• The results of prolonged action of GLP-1 on some metabolic parameters.

  2011cites this paper
• Jejunum Inflammation in Obese and Diabetic Mice Impairs Enteric Glucose Detection and Modifies Nitric Oxide Release in the Hypothalamus

  2011cites this paper
• GLP-1, the gut-brain, and brain-periphery axes.

  2011cites this paper
• Running title : Heat treated diets and glucose homeostasis Word Count : 5372 Number of Figures : 4 Number of Tables : 1 List of author ’ s names for Pubmed indexing

  2011cites this paper
• Brain GLP-1 Signaling Regulates Femoral Artery Blood Flow and Insulin Sensitivity Through Hypothalamic PKC-δ

  2011cites this paper
• Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.

  2011cites this paper
• Glucagon‐like peptide‐1(9‐36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet‐induced obese mice

  2011cites this paper
• GLP-1 and energy balance: an integrated model of short-term and long-term control

  2011cites this paper
• Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control

  2011cites this paper
• Central Apelin Controls Glucose Homeostasis via a Nitric Oxide-Dependent Pathway in Mice

  2011cites this paper
• Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.

  2011cites this paper
• Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet.

  2011cites this paper
• Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.

  2011cites this paper
• Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function

  2011cites this paper
• Is the GLP-1 system a viable therapeutic target for weight reduction?

  2011cites this paper
• Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design.

  2010cites this paper
• Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system.

  2010cites this paper
• GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.

  2010cites this paper
• The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell

  2010cites this paper
• GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs

  2010cites this paper
• Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.

  2010cites this paper
• Central GLP-1 actions on energy metabolism.

  2010cites this paper
• Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides.

  2010cites this paper
• Regulation of lipid metabolism by energy availability: a role for the central nervous system

  2010cites this paper
• Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.

  2010cites this paper
• Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.

  2010cites this paper
• Direct Control of Peripheral Lipid Deposition by CNS GLP-1 Receptor Signaling Is Mediated by the Sympathetic Nervous System and Blunted in Diet-Induced Obesity

  2009cites this paper
• Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats

  2009cites this paper
• The role of the gut microbiota in energy metabolism and metabolic disease.

  2009cites this paper
• The effect of antidiabetic drugs on genes regulating lipid metabolism

  2009cites this paper